Understanding how stem cells become specialized cells through gene regulation.
Programmable depletion and rescue platform to screen dynamic regulatory events during cellular differentiation.
This study is looking at how stem cells turn into different types of cells by understanding how genes are controlled, and it aims to create a new tool to track and adjust the process of gene activity, which could help us learn more about how cells develop.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10910543 on NIH RePORTER |
What this research studies
This research investigates the intricate processes that allow stem cells to differentiate into specialized cells by focusing on the regulation of gene expression. It aims to develop a novel platform that can precisely monitor and manipulate mRNA degradation during the differentiation process, which has been a poorly understood aspect of cellular development. By utilizing advanced technologies, the research will explore how specific RNA degradation complexes influence gene expression at critical moments, providing insights into the dynamic nature of cell differentiation.
Who could benefit from this research
Good fit: Ideal candidates for this research would include individuals with conditions that could benefit from advancements in stem cell therapies or regenerative medicine.
Not a fit: Patients with conditions unrelated to stem cell differentiation or those not seeking regenerative therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for manipulating stem cell differentiation, potentially enhancing regenerative medicine and treatment for various diseases.
How similar studies have performed: While the exploration of mRNA degradation in differentiation is a relatively novel approach, previous studies have shown success in understanding gene regulation during cellular processes, indicating potential for impactful findings.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Zaccara, Sara — Columbia University Health Sciences
- Study coordinator: Zaccara, Sara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.